Literature DB >> 30529062

Treatment can be continued for mild cutaneous reactions associated with efavirenz.

Thuraya Isaacs1, Reginald Mduzumile Ngwanya1, Sipho Dlamini2, Jonny Peter3, Rannakoe Lehloenya4.   

Abstract

Entities:  

Year:  2018        PMID： 30529062      PMCID： PMC7045143          DOI： 10.1016/j.jaip.2018.11.041

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  7 in total

1.  Cutaneous adverse drug reactions caused by FDCAs - we need to characterise and manage them urgently.

Authors:  Rannakoe J Lehloenya; Thuraya Isaacs; Sipho Dlamini; Rudzani Muloiwa
Journal:  S Afr Med J       Date:  2013-11

2.  Identification of a novel and severe pattern of efavirenz drug-induced liver injury in South Africa.

Authors:  Mark W Sonderup; Debbie Maughan; Neliswa Gogela; Mashiko Setshedi; Helen Wainwright; Graeme Meintjes; Wendy Spearman
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases.

Authors:  Thuraya Isaacs; Mzudumile R Ngwanya; Sipho Dlamini; Rannakoe J Lehloenya
Journal:  J Antimicrob Chemother       Date:  2013-07-12       Impact factor: 5.790

5.  [Cutaneous drug-reactions to nevirapine: study of risk factors in 101 HIV-infected patients].

Authors:  P Pitche; C Drobacheff-Thiebaut; B Gavignet; M Mercier; R Laurent
Journal:  Ann Dermatol Venereol       Date:  2005-12       Impact factor: 0.777

6.  Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.

Authors:  Phumla Z Sinxadi; Paul D Leger; Helen M McIlleron; Peter J Smith; Joel A Dave; Naomi S Levitt; Gary Maartens; David W Haas
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

7.  Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.

Authors:  Pei-Ying Wu; Chien-Yu Cheng; Chun-Eng Liu; Yi-Chien Lee; Chia-Jui Yang; Mao-Song Tsai; Shu-Hsing Cheng; Shih-Ping Lin; De-Yu Lin; Ning-Chi Wang; Yi-Chieh Lee; Hsin-Yun Sun; Hung-Jen Tang; Chien-Ching Hung
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240
  7 in total
  2 in total

Review 1.  Drug hypersensitivity in HIV infection.

Authors:  Jonny Peter; Phuti Choshi; Rannakoe J Lehloenya
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08

2.  Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?

Authors:  Rannakoe J Lehloenya; Jonny G Peter; Ana Copascu; Jason A Trubiano; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.